---
description:
globs:
alwaysApply: false
---
# CrisPRO Platform Overview

## Mission Statement
CrisPRO is an AI-powered, end-to-end CRISPR therapeutic design platform that moves beyond fragmented bioinformatics tools to offer integrated, therapeutically-focused solutions for both prophylactic and therapeutic interventions.

## Core Value Proposition
- **Prophylactic Strategy Design**: Unique focus on designing CRISPR corrections for pathogenic germline mutations to *prevent* disease onset
- **AI-Enhanced Decision Making**: LLM-powered interpretation of bioinformatics data with therapeutic context
- **Digital Twin Simulation**: Predictive modeling of editing outcomes, cellular impacts, and therapeutic efficacy
- **End-to-End Integration**: Seamless workflow from variant analysis to experimental design to validation planning

## Key Platform Modules

### 1. CRISPR Prophylactic Strategy Simulator & Designer (Flagship)
- Optimal Corrective Edit Design Engine
- Digital Twin - Cellular Risk Model simulation
- Off-Target Validation Strategy Design
- Predicted Correction Longevity (PCL) metrics

### 2. Intelligent Genetic Variant Interpretation
- AI-driven pathogenicity assessment
- VUS classification using structural modeling
- Therapeutic prioritization algorithms

### 3. AI-Guided Strategy Selection
- Context-aware CRISPR modality recommendations
- Nuclease/editor selection optimization
- Delivery system matching

### 4. Somatic Mutation Targeting & Mosaicism Modeling
- Tumor-specific target identification
- VAF-based editing efficiency predictions
- Resistance mechanism modeling

### 5. Comprehensive Safety & Immunogenicity Prediction
- Off-target risk assessment
- Immunogenicity scoring for nucleases and vectors
- Mitigation strategy recommendations

## Strategic Differentiators
- **Therapeutic Context Enabled Mode**: Platform behavior adapts based on disease area and intervention goals
- **Literature Integration**: Automated PubMed analysis with therapeutic relevance scoring
- **Experiment Design Assistance**: IND-enabling study recommendations
- **Multi-Agent Collaboration**: Specialized AI agents working together for optimal outcomes

## Target Users
- CRISPR researchers transitioning to therapeutic applications
- Biotech companies developing gene therapies
- Clinical researchers planning CRISPR trials
- Genetic counselors assessing intervention options

## Development Status
- Core LLM integration: âœ… Complete
- CHOPCHOP workflow enhancement: âœ… Complete  
- Experiment design automation: âœ… Complete
- Therapeutic context integration: ðŸš§ In Progress
- Literature analysis pipeline: ðŸš§ In Progress
- Patent application: ðŸ“‹ Strategic phase

## Reference Files
- Main application: [app.py](mdc:app.py)
- Scratchpad and progress: [.cursorrules](mdc:.cursorrules)
- Strategic themes: [crispro_strategic_themes.mdc](mdc:crispro_strategic_themes.mdc)
- Patent overview: [crispro_patent_overview.mdc](mdc:crispro_patent_overview.mdc)
